Skip to main content
Premium Trial:

Request an Annual Quote

GenoSpectra Closes $20M Series B Financing Round

NEW YORK, Dec. 20 - Start-up genomic tool company GenoSpectra has closed on $20 million in a Series B round of private equity financing, the company said on Wednesday.

 

The round was led by Frazier Healthcare Ventures, and the BioMedical Sciences Investment Fund of the Singapore Economic Development Board, HBM BioVentures, and Novartis BioVentures tagged along.

 

The Fremont, Calif.-based firm develops DNA and protein microarrays as well as tools for high throughput drug screening.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.